Mucomucil (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucomucil, is a mucolytic presented as an injectable solution for intravenous use. It is employed to thin mucus in acute and chronic respiratory conditions and to prevent liver injury in acetaminophen (paracetamol) overdose.

GNH USA supplies Mucomucil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mucomucil is a mucolytic that acts on respiratory secretions and on toxic metabolites of acetaminophen. - Acute respiratory conditions: reduces mucus viscosity to improve airway clearance. - Chronic bronchitis and COPD: facilitates expectoration and eases breathing. - Acetaminophen overdose: replenishes glutathione stores to protect the liver from toxic metabolites.

Adverse reactions may occur with intravenous acetylcysteine administration.

Common Side Effects: - Nausea: mild to moderate feeling of queasiness. - Vomiting: occasional emesis during infusion. - Flushing: transient redness of the skin. - Headache: mild to moderate intensity. - Hypotension: mild drop in blood pressure during infusion. - Rash: mild erythematous skin reaction.

Serious or Rare Side Effects: - Anaphylactoid reaction: sudden bronchospasm, urticaria, or angioedema. - Severe hypotension: marked drop in blood pressure requiring intervention. - Bronchospasm: acute narrowing of airways, especially in asthmatic patients. - Stevens‑Johnson syndrome: rare severe skin eruption.

When using Mucomucil, clinicians should consider several safety measures. - Renal impairment: adjust infusion rate and monitor renal function. - Asthma or reactive airway disease: observe closely for bronchospasm. - Hepatic dysfunction: assess baseline liver enzymes before therapy. - Concomitant nitroglycerin: avoid due to risk of additive hypotension. - Pregnancy: category unknown; use only if potential benefit justifies risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Acetylcysteine may interact with other agents administered intravenously.

Major Interactions (Avoid): - Nitroglycerin: combined use can cause profound hypotension. - Activated charcoal: may adsorb acetylcysteine and reduce its effectiveness. - High‑dose vitamin C: potential for increased oxidative stress.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): monitor INR as acetylcysteine may alter bleeding risk. - ACE inhibitors: watch for additive blood pressure lowering effects. - Diuretics: monitor electrolytes, especially potassium, during therapy.